Covered recipient · General Payments record
LAUREN E GRANGER
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2023
$991.80
- Reported across 57 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $336.38 | 17 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corium, Inc. | $153.38 | 6 |
| Tris Pharma Inc | $44.99 | 3 |
| IRONSHORE PHARMACEUTICALS INC. | $43.30 | 2 |
| Merck Sharp & Dohme Corporation | $29.69 | 2 |
| Acerta Pharma LLC | $18.20 | 1 |
| PFIZER INC. | $17.86 | 1 |
| Cranial Technologies, Inc | $14.86 | 1 |
| Supernus Pharmaceuticals, Inc. | $14.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $18.20 | 10/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014867903 | CMS |
| Corium, LLC | $17.58 | 01/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 977988200 | CMS |
| Corium, LLC | $25.91 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 977988210 | CMS |
| Corium, LLC | $21.85 | 04/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978158555 | CMS |
| Corium, LLC | $29.89 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978158545 | CMS |
| Corium, LLC | $33.75 | 07/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978479751 | CMS |
| Corium, LLC | $24.40 | 08/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978479758 | CMS |
| Cranial Technologies, Inc | $14.86 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1035772165 | CMS |
| Ironshore Pharmaceuticals Inc. | $20.53 | 01/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060457193 | CMS |
| Ironshore Pharmaceuticals Inc. | $22.77 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060457273 | CMS |
| Merck Sharp & Dohme LLC | $13.94 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048896521 | CMS |
| Merck Sharp & Dohme LLC | $15.75 | 09/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048927573 | CMS |
| PFIZER INC. | $17.86 | 05/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050366655 | CMS |
| Supernus Pharmaceuticals, Inc. | $14.10 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053300667 | CMS |
| Tris Pharma Inc | $13.40 | 01/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059334311 | CMS |
| Tris Pharma Inc | $14.32 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059334363 | CMS |
| Tris Pharma Inc | $17.27 | 05/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059334371 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.